U-47700
Synthetic opioid analgesic
U-47700 | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | 82657-23-6 |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
U-47700 is a synthetic opioid analgesic drug developed by Upjohn in the 1970s. It is structurally related to other opioids such as AH-7921 and is known for its potent analgesic effects. U-47700 has gained notoriety as a designer drug and has been associated with numerous cases of overdose and fatalities.
Chemical structure and properties
U-47700 is a member of the benzamide class of opioids. Its chemical structure is characterized by a 3,4-dichlorophenyl group attached to a methanone moiety, with a dimethylamino group at the 1-position and a methyl group at the 2-position of the propyl chain. This structure contributes to its high affinity for the mu-opioid receptor, which is responsible for its analgesic and euphoric effects.
Pharmacology
U-47700 acts primarily as a mu-opioid receptor agonist, similar to other opioids such as morphine and fentanyl. It produces effects such as pain relief, sedation, and euphoria. However, it also carries a high risk of respiratory depression, which can be fatal in overdose situations. The potency of U-47700 is estimated to be several times that of morphine.
Legal status
Due to its potential for abuse and associated health risks, U-47700 has been classified as a controlled substance in many countries. In the United States, it was temporarily placed in Schedule I of the Controlled Substances Act in 2016, indicating that it has a high potential for abuse and no accepted medical use.
Health risks and safety
The use of U-47700 has been linked to numerous adverse effects, including respiratory depression, cardiac arrest, and death. It is often found in combination with other substances, which can increase the risk of overdose. Users may also experience withdrawal symptoms similar to those of other opioids.
Related pages
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD